Stock Price
0.47
Daily Change
0.01 1.09%
Monthly
-5.10%
Yearly
365.00%
Q1 Forecast
0.40

Starpharma Holdings reported AUD10.83M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025